Stay updated on JAK1 Inhibitor With Topical Therapy Clinical Trial
Sign up to get notified when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.

Latest updates to the JAK1 Inhibitor With Topical Therapy Clinical Trial page
- Check6 days agoChange DetectedRevision metadata updated from v3.6.0 to v3.6.3, representing a small backend or documentation update. No substantive changes to the study information or user-facing content are indicated.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew sections were added to help readers read and join a study and answer common questions (How to Read a Study Record, Common Questions, How to Join a Study), and the page now indicates recruitment has ceased. A formatting change from 'Intervention / Treatment' to 'Intervention/Treatment' and a revision version bump to v3.6.0 are also observed.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4. This signals a minor update to the page versioning rather than a substantive change to its content.SummaryDifference0.0%

- Check41 days agoChange DetectedA new publication citation has been added under the Publications section, referencing a related study on abrocitinib for atopic dermatitis. This expands the study record with related literature without changing the trial's design or status.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page revision tag has been updated to v3.5.4. This is a minor metadata update with no impact on the page content or its use.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page’s release/revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to JAK1 Inhibitor With Topical Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.